Skip to content

Human Phenotype Project Study Protocol

Longitudinal Collection of Observational Clinical and Lifestyle Data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05817734
Enrollment
30000
Registered
2023-04-18
Start date
2018-10-01
Completion date
2045-12-31
Last updated
2024-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Disease

Brief summary

This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis. The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.

Interventions

None listed

Sponsors

Weizmann Institute of Science
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ages 18+, males and females.

Exclusion criteria

* Pregnancy. * Mentally disabled or in general legally non-competent. * Prisoner or soldier. Soldiers: mandatory service only * Active cancer * Fertility Treatments (current) * Hepatitis ( B, C), chronic or acute * HIV * Liver cirrhosis * Dialysis * Unstable medical conditions

Design outcomes

Primary

MeasureTime frameDescription
Adult disease25 yearsDevelopment of medical conditions based on participant's self-reporting coded to ICD11.

Countries

Israel

Contacts

Primary ContactEran Segal, Prof.
Eran.Segal@weizmann.ac.il972-8-9343266

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026